News Fredun Pharmaceuticals Limited

Equities

FREDUN6

INE194R01017

Market Closed - Bombay S.E. Other stock markets 03:30:53 17/05/2024 pm IST			5-day change	1st Jan Change
870.4 ^INR	-1.02%		+4.13%	+0.18%

10/05	Fredun Pharmaceuticals Limited Proposes Final Dividend for the Financial Year 2023-24	CI
08/05	Fredun Pharmaceuticals' Net Profit Jumps in Fiscal Q4; Shares Dip 9%	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Fredun Pharmaceuticals Limited Proposes Final Dividend for the Financial Year 2023-24	10/05	CI
Fredun Pharmaceuticals' Net Profit Jumps in Fiscal Q4; Shares Dip 9%	08/05	MT
Fredun Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended March 31, 2024	07/05	CI
Fredun Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	07/05	CI
Fredun Pharmaceuticals Secures Orders from Sea Countries, Expands Product Development in Veterinary Care, and Advances Orthopaedic Applications	12/02	CI
Fredun Pharmaceuticals Limited Announces Appointment of Ms. Daisy Cyril Dsouza as Additional Independent Director	24/11	CI
Fredun Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	08/11	CI
Fredun Pharmaceuticals Limited Declared A Dividend At 7% on the Equity Shares of the Company for the Financial Year Ended March 31, 2023	30/23/30	CI
Fredun Pharmaceuticals Limited Proposes Dividend for the Financial Year Ended March 31, 2023	06/23/06	CI
Fredun Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	19/23/19	CI
Fredun Pharmaceuticals Limited Approves the Resignation of Dr. Chandrakant Shah as Independent Director	19/23/19	CI
Fredun Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	25/23/25	CI
Fredun Pharmaceuticals Limited Recommends Final Dividend for the Financial Year 2022-23	25/23/25	CI
Fredun Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	27/23/27	CI
Fredun Pharmaceuticals Limited announced that it has received INR 275.691377 million in funding	27/22/27	CI
Fredun Pharmaceuticals Limited Announces Change in Registered Office Address	13/22/13	CI
Fredun Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	10/22/10	CI
Fredun Pharmaceuticals Limited Approves Dividend for the Financial Year Ended March 31, 2022	30/22/30	CI
Fredun Pharmaceuticals Limited announced that it expects to receive INR 284.662157 million in funding	27/22/27	CI
Fredun Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	12/22/12	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Fredun Pharmaceuticals Limited

Equities

FREDUN6

INE194R01017

Summary

Filters